External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology Macula Society 2025
Roche and Genentech at

Macula Society 2025

February 12 - February 15
Florida, USA
maculasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:04 PM
Duration 5mins United States
Treatment Response and Safety of Faricimab▼ in Underrepresented Patients With DME: Year 1 Results From ELEVATUM in the US
Scott A, Amador M, Brown J, Cunningham M, Coney J, Emanuelli A, Huddleston S, Milunovich S, Yang M, Lu XY, Gonzalez L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:09 PM
Duration 5mins United States
Four-Year Outcomes of Faricimab▼ in DME: Safety and Efficacy Results From The RHONE-X Long-Term Extension Trial
Khanani A, Abreu F, Gibson K, Kotak A, Lai TYY, Pearce I, Schlottmann P, Sim D, Tang Y, Kotecha A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:14 PM
Duration 5mins United States
Greater reduction in hard exudates with faricimab▼ vs aflibercept in patients with DME: biomarker results from the phase 3 YOSEMITE/RHINE trials
Elman M, Pollreisz A, Dinah C, Goldberg R, Ip M, Rahimy E, Vujosevic S, Amador M, Gibson K, Maunz A, O'Leary O, Uschner D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:50 PM
Duration 5mins United States
Impact of Early Intraretinal Fluid Reduction on One-Year Outcomes in Diabetic Macular Edema
Chan C, Sadda S, Lim J, Wang Y, Hibar D, Maunz A, Lu H, Albrecht T, Amador M, Gibson K, Litts K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:25 PM
Duration 5mins United States
Global Real-World Clinical and Anatomical Outcomes With Faricimab▼ in Treatment-Naïve Patients With nAMD or DME From a Multi-Country Prospective Non-Interventional Study: The VOYAGER Study
Schmitz-Valckenberg S, Bailey C, Chaikitmongkol V, Chaudhary V, Chi G, Downey A, Finger R, Gallego-Pinazo R, Koh A, Ishida S, Lövestam-Adrian M, Parravano M, Pinto JL, Sheth V, Shi B, Souied E, Uschner D, Guymer R
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:30 PM
Duration 5mins United States
Treatment Patterns, Visual Outcomes, and Safety in Eyes With nAMD and DME Treated With Faricimab▼ in the UK: 1-Year Results From the FARWIDE Study
Sivaprasad S, Pearce I, Talks J, Salvo G, Patel P, Silva S, Gale R, McKibbin M, Varma D, Peto T, Reynolds R, Bailey C, Downey L, Kiire C, Chi G, Dodds M, James N, Downey A, Dayal P
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:35 PM
Duration 5mins United States
Real-World Clinical Outcomes Update in Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) Treated With Faricimab▼ in the US: The FARETINA Study
Borkar D, Zwick E, Bonine N, Leng T, Ko S, Shaia J, Ali F, Singh R
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:50 PM
Duration 10mins United States
Clinical Impact of Continuous Drug Delivery With the PDS in Patients With nAMD
Arevalo JF, Chakravarthy U, Rachitskaya A, Holekamp N, Blotner S, Garcia Armendariz B, Heinrich D
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:20 PM
Duration 10mins United States
Comparative Efficacy of Faricimab▼ for the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis
Wells J, Lupidi M, Keane P, Holekamp N, Leng T, Siedlecki J, Mar F, Gibson K, Margaron P, Paulo T, Buehrer C, Tabano D
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:40 PM
Duration 10mins United States
Baseline and Early Treatment Response Variables Associated With Faricimab▼ Durability in Treatment-nave nAMD: TENAYA/LUCERNE Post Hoc Analyses
Tan C, Gallego-Pinazo R, Koh A, Pitcher J, Dagincourt N, Hill L, Patel S, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:50 PM
Duration 10mins United States
Faricimab▼ for Polypoidal Choroidal Vasculopathy: Week 16 Results From the Phase 3b/4 SALWEEN Trial
Cheung G, Chen SJ, Iida T, Koh A, Lee WK, Ruamviboonsuk P, Sun X, Yanagi Y, Bai R, Margaron P, Nguyen Duc A, Lai TYY
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:20 PM
Duration 5mins United States
Interleukin-6 Inhibition With Vamikibart in Patients With Uveitic Macular Edema: DOVETAIL, MEERKAT, and SANDCAT Trials
Holecamp N, Lin P, Steeples L, Elze M, Macgregor L, Stoilov I, Silverman D, Mesquida M, Haskova Z
Ophthalmology | Uveitis

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:35 PM
Duration 5mins United States
Implementation of Optimized Surgical Steps for the PDS and the Incidence of Endophthalmitis and Associated Patient Outcomes
Chaudhry N, Campochiaro P, Chang M, Pieramici P, Regillo C, Bobbala A, Gune S, Jaycock P, Kardatzke D, Prager A, Singh N
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Retinopathy - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:20 PM
Duration 10mins United States
Retinal Fluid and Thickness Fluctuations in Pagoda Trial of PDS in Patients With DME
Tan G, D Marcus, Awh C, Eter N, Hatz K, Menezes A, Eghoej M, Gordon A, Blotner S, Heinrich D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.